Brain Tumor Clinical Trials
Researchers conduct brain tumor clinical trials to determine the best ways to use promising new therapies for patients with brain cancer. All new treatments must go through the clinical trial process before they are approved for widespread use; this allows researchers to identify when the treatments are most effective, how they interact with other treatments and which types of brain cancer benefit from the treatments the most.
At Moffitt Cancer Center, we know that every clinical trial gets us one step closer to a cure. That’s why our oncologists are constantly exploring promising new treatments such as novel chemotherapy agents, biological therapies and vaccines. Because of these ongoing efforts, we have been named a National Cancer Institute-designated Comprehensive Cancer Center, the only one based in Florida.
Through Moffitt’s clinical trial program, patients have access to promising brain tumor therapies that:
- Have the potential to be more effective than the current standard of care, since most existing brain cancer treatments are not considered to be curative.
- Can improve not only their prognoses, but also their quality of life. Clinical trial participants are the first to benefit if a new treatment is found to be effective.
- Are hand-selected for their unique situations based on the results of next-generation sequencing tests. To match patients with the most appropriate trials, Moffitt’s oncologists consider several factors, including the biological activity of a patient’s tumor.
- Are administered and supervised by a multispecialty team of oncologists who focus exclusively on the treatment of brain cancer. This way, changes can be made if a patient’s tumor does not respond positively to the therapy being tested.
To learn more about brain tumor clinical trials at Moffitt Cancer Center, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.